LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 62.29 | 84.90 | 753 | 7934 | 0.0949 | 0.3957 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 62.29 | 84.90 | 7225 | 7934 | 0.9106 | 0.9716 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 62.29 | 84.90 | 783 | 7934 | 0.0987 | 0.4041 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 62.29 | 84.90 | 9137 | 7934 | 1.1516 | 1.0436 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 63.99 | 84.90 | 778 | 8212 | 0.0947 | 0.3991 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 63.99 | 84.90 | 7535 | 8212 | 0.9175 | 0.9741 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 63.99 | 84.90 | 793 | 8212 | 0.0966 | 0.4032 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 63.99 | 84.90 | 9479 | 8212 | 1.1542 | 1.0440 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 65.70 | 84.90 | 809 | 8484 | 0.0954 | 0.4041 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 65.70 | 84.90 | 7917 | 8484 | 0.9331 | 0.9793 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 65.70 | 84.90 | 710 | 8484 | 0.0837 | 0.3767 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 65.70 | 84.90 | 9853 | 8484 | 1.1613 | 1.0455 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 67.41 | 84.90 | 835 | 8766 | 0.0953 | 0.4073 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 67.41 | 84.90 | 8195 | 8766 | 0.9348 | 0.9800 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 67.41 | 84.90 | 753 | 8766 | 0.0859 | 0.3858 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 67.41 | 84.90 | 10126 | 8766 | 1.1551 | 1.0436 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 69.11 | 84.90 | 870 | 8988 | 0.0968 | 0.4134 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 69.11 | 84.90 | 8423 | 8988 | 0.9371 | 0.9808 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 69.11 | 84.90 | 739 | 8988 | 0.0822 | 0.3795 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 69.11 | 84.90 | 10412 | 8988 | 1.1584 | 1.0442 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 70.81 | 84.90 | 891 | 9132 | 0.0976 | 0.4167 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 70.81 | 84.90 | 8693 | 9132 | 0.9519 | 0.9855 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 70.81 | 84.90 | 739 | 9132 | 0.0809 | 0.3780 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 70.81 | 84.90 | 10589 | 9132 | 1.1595 | 1.0444 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 72.52 | 84.90 | 962 | 9214 | 0.1044 | 0.4319 | MN20160318_Q02 | D17 |